Genentech

HERCEPTIN HYLECTA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / HERCEPTIN HYLECTA – J9356

Manufacturer:

Genentech

Name:

HERCEPTIN HYLECTA

HCPCS Code Descriptor:

Injection, trastuzumab, 10 mg and hyaluronidase-oysk

Category:

J Code

HCPCS:

J9356

NDC(s):

50242-0077-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

HERCEPTIN HYLECTA is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9356 is aligned to the drug HERCEPTIN HYLECTA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/19

HCPCS Effective Date:

7/1/19

HCPCS Short Description:

Inj. herceptin hylecta, 10mg

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Herceptin-Hylecta-Billing-Coding-for-Breast-Cancer.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation